The global RFID blood monitoring systems market is poised for remarkable growth, with sales projected to increase from USD 127.4 million in 2024 to USD 234.7 million by 2034. This forecast reflects a robust compound annual growth rate (CAGR) of 6.30% over the next decade, driven by the increasing adoption of RFID technology across healthcare facilities worldwide.
In 2023, the market generated revenues of USD 119.8 million, with expectations for a year-over-year growth of 6.34% in 2024. This upward trend is fueled by the rising demand for efficient and accurate blood management systems, crucial for ensuring patient safety and operational efficiency.
RFID (Radio Frequency Identification) technology has revolutionized blood supply chain management by facilitating real-time tracking and monitoring of blood products. By employing RFID tags, hospitals and healthcare providers can enhance the accuracy and safety of blood transfusions, ultimately improving patient outcomes and reducing errors in storage and handling.
Throughout the forecast period, RFID technology is expected to dominate the blood monitoring systems sector, capturing an impressive 89.5% of the market share. This dominance underscores the growing significance of RFID in meeting the increasing demand for enhanced patient safety and streamlined healthcare operations.
The integration of RFID blood monitoring systems equips healthcare facilities to manage blood products more effectively, tackle critical challenges in blood management, and ensure real-time visibility across the supply chain. As RFID technology continues to evolve, its role in transforming healthcare operations and enhancing patient care will further strengthen, propelling continued growth in the market.
Key Takeaways:
- The global RFID blood monitoring systems market is projected to grow from USD 127.4 million in 2024 to USD 234.7 million by 2034, with a CAGR of 6.30% during the forecast period.
- The market is driven by factors such as the increasing demand for efficient blood management solutions, rising healthcare costs, and technological advancements in RFID technology.
- North America is the largest market for RFID blood monitoring systems, followed by Europe and Asia Pacific.
- The market in Germany is expected to grow at a CAGR of 2.2% during the forecast period.
- China is expected to be the fastest-growing market for RFID blood monitoring systems, with a CAGR of 6.9% during the forecast period.
High Demand for Market Insights: Discover Comprehensive Trends in Our Full Report!
Competitive Landscape:
Key players in the RFID blood monitoring systems market are investing heavily in developing advanced RFID products. Many blood product manufacturers are integrating RFID technology to optimize the management and tracking of their blood inventories. Additionally, companies are forming partnerships with industry leaders to expand their market presence and reach new regions.
Recent Industry Developments in RFID Blood Monitoring Systems Market:
- March 2024: Mymediset and Terso Solutions announced a partnership to launch mymindset LiveSync, a groundbreaking platform designed to transform the monitoring, tracking, and management of consigned inventory.
- October 2022: Biolog-id introduced an innovative RFID kit specifically for organizations handling large volumes of Red Blood Cells (RBCs). This new HD kit has been successfully implemented at several client sites, showcasing its effectiveness in inventory management.
- September 2021: Biolog-id Blood Inventory Devices were deployed at the Scottish National Blood Transfusion Service (SNBTS) in Scotland, aiming to improve the organization’s blood product management.
Key Players of RFID Blood Monitoring Systems Industry:
- Biolog-id
- Mediware Information System
- Honeywell
- Nordic ID
- TAGSY RFID
- Zebra Technologies Wave Mark
- Log Tag
- Terso Solutions
- RFID Group
- Solstice Medical LLC
- Magellan Technologies
Key Segments of RFID Blood Monitoring Systems Industry:
By Product:
In terms of product, the industry is divided into systems and tags.
By End-use:
The industry is classified by end use industries blood banks, and hospital blood centers.
By Region:
Key countries of North America, Latin America, East Asia, South Asia, Western Europe, Eastern Europe, and Middle East and Africa (MEA), have been covered in the report.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube